BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17923099)

  • 21. A high-density screening format for encoded combinatorial libraries: assay miniaturization and its application to enzymatic reactions.
    Schullek JR; Butler JH; Ni ZJ; Chen D; Yuan Z
    Anal Biochem; 1997 Mar; 246(1):20-9. PubMed ID: 9056178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a new alpha1,2-fucosyltransferase involved in O-antigen biosynthesis of Escherichia coli O86:B7 and formation of H-type 3 blood group antigen.
    Li M; Shen J; Liu X; Shao J; Yi W; Chow CS; Wang PG
    Biochemistry; 2008 Nov; 47(44):11590-7. PubMed ID: 18842005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two time-resolved fluorometric high-throughput assays for quantitation of GDP-L-fucose.
    Räbinä J; Mattila P; Renkonen R
    Anal Biochem; 2000 Nov; 286(1):173-8. PubMed ID: 11038288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stachybotrydial, a potent inhibitor of fucosyltransferase and sialyltransferase.
    Lin TW; Chang WW; Chen CC; Tsai YC
    Biochem Biophys Res Commun; 2005 Jun; 331(4):953-7. PubMed ID: 15882970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of beta-D-Gal p-(1-->3)-beta-D-Glc pNAc-OR acceptor analogues by the Lewis alpha-(1-->3/4)-fucosyltransferase from human milk.
    Du M; Hindsgaul O
    Carbohydr Res; 1996 Jun; 286():87-105. PubMed ID: 8925514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fucosylation in prokaryotes and eukaryotes.
    Ma B; Simala-Grant JL; Taylor DE
    Glycobiology; 2006 Dec; 16(12):158R-184R. PubMed ID: 16973733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calculating the probability of detection for inhibitors in enzymatic or binding reactions in high-throughput screening.
    Buxser S; Vroegop S
    Anal Biochem; 2005 May; 340(1):1-13. PubMed ID: 15802124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A potent and highly selective inhibitor of human alpha-1,3-fucosyltransferase via click chemistry.
    Lee LV; Mitchell ML; Huang SJ; Fokin VV; Sharpless KB; Wong CH
    J Am Chem Soc; 2003 Aug; 125(32):9588-9. PubMed ID: 12904015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a microplate-based scintillation proximity assay for MraY using a modified substrate.
    Solapure SM; Raphael P; Gayathri CN; Barde SP; Chandrakala B; Das KS; De Sousa SM
    J Biomol Screen; 2005 Mar; 10(2):149-56. PubMed ID: 15799958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extending matrix-assisted laser desorption/ionization triple quadrupole mass spectrometry enzyme screening assays to targets with small molecule substrates.
    Rathore R; Corr JJ; Lebre DT; Seibel WL; Greis KD
    Rapid Commun Mass Spectrom; 2009 Oct; 23(20):3293-300. PubMed ID: 19757451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycosyltransferase activity can be modulated by small conformational changes of acceptor substrates.
    Galan MC; Venot AP; Boons GJ
    Biochemistry; 2003 Jul; 42(28):8522-9. PubMed ID: 12859199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning and expression of rat fucosyltransferase VII at sites of inflammation.
    Niittymäki J; Mattila P; Renkonen R
    APMIS; 2005 Sep; 113(9):613-20. PubMed ID: 16218937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a novel alpha1,2-fucosyltransferase of Escherichia coli O128:b12 and functional investigation of its common motif.
    Li M; Liu XW; Shao J; Shen J; Jia Q; Yi W; Song JK; Woodward R; Chow CS; Wang PG
    Biochemistry; 2008 Jan; 47(1):378-87. PubMed ID: 18078329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
    Snowden M; Green DV
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high-throughput pH indicator assay for screening glycosyltransferase saturation mutagenesis libraries.
    Persson M; Palcic MM
    Anal Biochem; 2008 Jul; 378(1):1-7. PubMed ID: 18405657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.
    Kolb P; Kipouros CB; Huang D; Caflisch A
    Proteins; 2008 Oct; 73(1):11-8. PubMed ID: 18384152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic Synthesis of a Fluorogenic Reporter Substrate and the Development of a High-Throughput Assay for Fucosyltransferase VIII Provide a Toolkit to Probe and Inhibit Core Fucosylation.
    Soroko M; Kwan DH
    Biochemistry; 2020 Jun; 59(22):2100-2110. PubMed ID: 32441090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a fluorescence-based enzyme assay of human 5-lipoxygenase.
    Pufahl RA; Kasten TP; Hills R; Gierse JK; Reitz BA; Weinberg RA; Masferrer JL
    Anal Biochem; 2007 May; 364(2):204-12. PubMed ID: 17376394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.